Immuneering (IMRX) Other Working Capital Changes (2020 - 2024)
Historic Other Working Capital Changes for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to -$1.5 million.
- Immuneering's Other Working Capital Changes fell 176198.08% to -$1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$300102.0, marking a year-over-year increase of 2075.95%. This contributed to the annual value of -$300102.0 for FY2024, which is 2075.95% up from last year.
- Latest data reveals that Immuneering reported Other Working Capital Changes of -$1.5 million as of Q4 2024, which was down 176198.08% from $644549.0 recorded in Q3 2024.
- Over the past 5 years, Immuneering's Other Working Capital Changes peaked at $2.4 million during Q3 2022, and registered a low of -$1.5 million during Q4 2024.
- Moreover, its 5-year median value for Other Working Capital Changes was -$74872.5 (2020), whereas its average is $98477.5.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 97862.83% in 2021, then plummeted by 205184.91% in 2023.
- Over the past 5 years, Immuneering's Other Working Capital Changes (Quarter) stood at -$70051.0 in 2020, then plummeted by 918.63% to -$713561.0 in 2021, then skyrocketed by 100.57% to $4083.0 in 2022, then crashed by 2051.85% to -$79694.0 in 2023, then crashed by 1761.98% to -$1.5 million in 2024.
- Its last three reported values are -$1.5 million in Q4 2024, $644549.0 for Q3 2024, and $788131.0 during Q2 2024.